You won't find GLP-1 on a nutrition label or in a fitness app
Home Bedding Market Size The global GLP-1 receptor agonist market reached a value of nearly $65,865.6 million in 2025, having grown at a compound annual growth rate (CAGR) of 37.0% since 2020
Specific concerns related to GLP1 receptor agonists can be broadly classified into the following categories: side effects/safety, access, and medication adherence
We Thank God for the Greatness happening thru these hands " Angie A
Dizziness In some instances, semaglutide usage may lead to occasional episodes of dizziness or lightheadedness (8% with Wegovy)
Request referral to appropriate specialists if needed Liver assessment : Ensure proper diagnosis through blood tests, FIB-4 calculation, and if indicated, imaging (ultrasound or FibroScan) or ELF testing Specialist review : Hepatology or endocrinology input may be needed to assess suitability Clinical trials : Some patients may be eligible for research studies examining GLP-1 agonists in NAFLD/NASH Patients should be aware that even when prescribed, GLP-1 agonists require ongoing monitoring, lifestyle modification remains essential, and treatment should be reviewed regularly to assess response and tolerability
